Eli Lilly

Major pharmaceutical companies like Eli Lilly are exploring how psychedelics might be used to treat mental health disorders like PTSD or treatment-resistant depression.

GLP-1 weight loss drugs are increasingly popular as a treatment for obesity. But a lot of employer-sponsored health plans won’t cover the treatments, especially at small and medium-sized firms. 

After years of wide-open compounding, regulators say they’re ready to enforce limits and restore control over the fast-growing GLP-1 market.

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.

The drug maker announced it’s cutting the price of its most commonly-used insulins by 70%, and capping patients’ out-of-pocket cost at $35 at certain participating pharmacies.

Drugmaker Eli Lilly will supply the government with another 150,000 doses of its monoclonal antibody to meet short-term demand.

Lawmakers have been critical of big pharma's pricing structures.